Single User License: Aurora Kinase Inhibitors Market Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2015 - 2023 USD 4315.5     Transparency Market Research State Tower, 90, State Street, Suite 700. Albany, NY 12207 United States www.transparencymarketresearch.com [email protected] Flat 10% Discount!! Free Customization as per your requirement You will get Custom Report at Syndicated Report price Report will be delivered with in 15-20 working days Request Sample Buy Now REPORT DESCRIPTION The Aurora kinases are enzymes which are crucial for cell proliferation. These enzymes are responsible for dividing genetic material of the parent cell during the process of mitosis by controlling chromatid segregation. The defect related to this process is largely associated with cancer genesis in human body. In this way active involvement of aurora kinase enzymes in initiating cancer genesis has lead considerable attention of therapists to their inhibition in the work towards cancer treatment. There are three kind of aurora kinase found in human body namely A, B and C. Aurora C is mainly restricted to the process of spermatogenesis while remaining two are responsible various tumerogenesis. Browse Full market.html Report with TOC @ http://www.transparencymarketresearch.com/aurora-kinase-inhibitors- Cancer is considered to the major causative factor for mortality worldwide with increasing incidence and prevalence day by day. All regions of the world have seen continuous rise in number of cancer patients in past decade. WHO predicted that annual cancer cases will reach to 19.3 million by 2025 from the 14.1 million annually in year 2012, whereas annual cases in 2008 were 12.7 million of which 1.7 million were women newly diagnosed with breast cancer that accounted for 20% in 2008. WHO mentions that cancer kills 8.2 millions globally out of which 522,000 woman from breast cancer. It is mentionable that incidence rate is still higher in developed region whereas death rates are higher in less developed countries. In all the cancer types, number of patients suffering with head and neck, gastrointestinal, breast and uterine cancer are highest. Aurora family Kinase Assay/Inhibitor screening kits are designed to estimate the inhibitory effect of individual Aurora activity in the test chemical accurately. Merck Millipore, MBL International, Perkin Elmer, SignalChem are some of the leading companies which manufacture screening kits. Geographically North American region accounts for the largest market share in this market which is followed by developing Asia Pacific market and European market. The market for Aurora Kinase inhibitor is driven by continuous increasing number of cancer cases and improving healthcare standard outside the developed world and advancements in early diagnosis of cancer. However there are restrictions such as high cost involved in drug development, lower spending capacity of poorer countries and need of real time clinical data. There are different kind of biological therapies in oncology such as Tyrosine kinase inhibitor (includes erlotinib, imatinib, gefitinib, dasatinib, sunitinib, ruxolitinib, etc.), monoclonal antibodies (includes trastuzumab, bevacizumab and cetuximab, etc.) whereas some are in development stage such as Aurora Kinase Inhibitor (Hesperadine, VX-680). Currently there is no molecule is approved in this market however there are almost 30 molecules of Aurora Kinase inhibitor class in development stage at different levels. With increase in cancer patients the market for Aurora Kinase Inhibitor market is set to increase. Some of the major players in Aurora Kinase Inhibitor development market are Merck, Pfizer, Amgen, Millennium Pharmaceuticals, Cyclacel Pharmaceuticals, Bristol Myers Squibb. Along with these, there are companies such as Roche, Novartis, Eli Lilly, AstraZeneca, Celgene, Sanofi and GlaxoSmithKline have made their mark in oncology. This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include  North America  Asia Pacific  Europe  Middle East and Africa  Latin America This report provides comprehensive analysis of  Market growth drivers  Factors limiting market growth  Current market trends  Market structure  Market projections for upcoming years This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. Inquiry Before Buying: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4683 Latest Press Release Reports: http://www.transparencymarketresearch.com/press-releases.htm Latest Articles Reports: http://www.transparencymarketresearch.com/articles.htm Read More Reports on Biotechnology Market: http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html About Us Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge. Contact: Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: [email protected] Website: http://www.transparencymarketresearch.com/

The Aurora kinases are enzymes which are crucial for cell proliferation. These enzymes are responsible for dividing genetic material of the parent cell during the process of mitosis by controlling chromatid segregation. The defect related to this process is largely associated with cancer genesis in human body. In this way active involvement of aurora kinase enzymes in initiating cancer genesis has lead considerable attention of therapists to their inhibition in the work towards cancer treatment. There are three kind of aurora kinase found in human body namely A, B and C. Aurora C is mainly restricted to the process of spermatogenesis while remaining two are responsible various tumerogenesis. Browse Full Report with TOC @ http://www.transparencymarketresearch.com/aurora-kinase-inhibitors-market.html